Open label, multicenter, 28-week extension study of the safety and tolerability of memantine in patients with mild to moderate Alzheimer’s disease

被引：0
|
作者：
Brian R. Ott
Lesley M. Blake
Ethel Kagan
Malca Resnick
机构：
[1] Rhode Island Hospital – APC 6,The Alzheimer’s Disease & Memory Disorders Center
[2] Northwestern University,Department of Psychiatry
[3] Harborside Financial Center,Forest Laboratories, Inc.
来源：
Journal of Neurology | 2007年 / 254卷
关键词：
Alzheimer’s disease; memantine; open label; randomized controlled trial; ADAS-cog;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：351 / 358
页数：7
相关论文
共 50 条
  • [1] Open label, multicenter, 28-week extension study of the safety and tolerability of memantine in patients with mild to moderate Alzheimer's disease
    Ott, Brian R.
    Blake, Lesley M.
    Kagan, Ethel
    Resnick, Malca
    JOURNAL OF NEUROLOGY, 2007, 254 (03) : 351 - 358
  • [2] Safety and Tolerability of the Rivastigmine Patch Results of a 28-week Open-label Extension
    Grossberg, George
    Sadotvsky, Carl
    Foerstl, Haas
    Froelich, Lutz
    Nagel, Jennifer
    Tekin, Sibel
    Zechner, Stefanie
    Ros, Jacqueline
    Orgogozo, Jean-Marc
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2009, 23 (02) : 158 - 164
  • [3] A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease
    Ruether, E
    Husmann, R
    Kinzler, E
    Diabl, E
    Klingler, D
    Spatt, J
    Ritter, R
    Schmidt, R
    Taneri, Z
    Winterer, W
    Koper, D
    Kasper, S
    Rainer, M
    Moessler, H
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2001, 16 (05) : 253 - 263
  • [4] Efficacy and Safety of a Transdermal Donepezil Patch in Patients with Mild to Moderate Alzheimer's Disease: Open-Label, Extension Study
    Nakamura, Yu
    Omori, Takumi
    Kim, Rei
    Nishiyama, Kenichi
    Kikuchi, Takashi
    Ishikawa, Ichiro
    Aoki, Hiroshi
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 94 (02) : 685 - 693
  • [5] Tolerability and Safety of Souvenaid in Patients with Mild Alzheimer's Disease: Results of Multi-Center, 24-Week, Open-Label Extension Study
    Rikkert, Marcel G. M. Olde
    Verhey, Frans R.
    Blesa, Rafael
    von Arnim, Christine A. F.
    Bongers, Anke
    Harrison, John
    Sijben, John
    Scarpini, Elio
    Vandewoude, Maurits F. J.
    Vellas, Bruno
    Witkamp, Renger
    Kamphuis, Patrick J. G. H.
    Scheltens, Philip
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 44 (02) : 471 - 480
  • [6] Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer's disease: a multicenter, randomized, open-label, parallel-group study
    Choi, Seong Hye
    Park, Kyung Won
    Na, Duk L.
    Han, Hyun Jeong
    Kim, Eun-Joo
    Shim, Yong S.
    Lee, Jae-Hong
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (07) : 1375 - 1383
  • [7] An Open-Label, Multicenter Observational Study for Patients with Alzheimer's Disease Treated with Memantine in the Clinical Practice
    Stamouli, S. S.
    Tzanakaki, M.
    Giatas, S.
    Georgiadis, G.
    Papalexi, E.
    Parashos, I. A.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2011, 1 (01): : 10 - 19
  • [8] An Open-Label Exploratory Study with Memantine: Correlation between Proton Magnetic Resonance Spectroscopy and Cognition in Patients with Mild to Moderate Alzheimer's Disease
    Gordon, Marc L.
    Kingsley, Peter B.
    Goldberg, Terry E.
    Koppel, Jeremy
    Christen, Erica
    Keehlisen, Lynda
    Kohn, Nina
    Davies, Peter
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2012, 2 (01): : 312 - 320
  • [9] A 48-Week, Multicenter, Open-Label, Observational Study Evaluating Oral Rivastigmine in Patients with Mild-to-Moderate Alzheimer’s Disease in Taiwan
    Chiung-Chih Chang
    Giia-Sheun Peng
    Te-Jen Lai
    Chien-Hsun Li
    Ching-Kuan Liu
    Advances in Therapy, 2019, 36 : 1455 - 1464
  • [10] A 48-Week, Multicenter, Open-Label, Observational Study Evaluating Oral Rivastigmine in Patients with Mild-to-Moderate Alzheimer's Disease in Taiwan
    Chang, Chiung-Chih
    Peng, Giia-Sheun
    Lai, Te-Jen
    Li, Chien-Hsun
    Liu, Ching-Kuan
    ADVANCES IN THERAPY, 2019, 36 (06) : 1455 - 1464
12345